3SBio Inc. (1530.HK)
HKD 6.11
(-0.49%)
HKD 6.11
(-0.49%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 23.62 Billion CNY | 7.44% |
| 2022 | 21.98 Billion CNY | 14.45% |
| 2021 | 19.21 Billion CNY | 8.68% |
| 2020 | 17.67 Billion CNY | 19.37% |
| 2019 | 14.8 Billion CNY | 7.01% |
| 2018 | 13.83 Billion CNY | 0.63% |
| 2017 | 13.75 Billion CNY | 24.59% |
| 2016 | 11.03 Billion CNY | 66.49% |
| 2015 | 6.63 Billion CNY | 187.47% |
| 2014 | 2.3 Billion CNY | 81.85% |
| 2013 | 1.26 Billion CNY | -14.09% |
| 2012 | 1.47 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 23.94 Billion CNY | 0.0% |
| 2024 Q1 | 23.94 Billion CNY | 1.36% |
| 2023 Q1 | 23.16 Billion CNY | 5.37% |
| 2023 FY | 23.62 Billion CNY | 7.44% |
| 2023 Q4 | 23.62 Billion CNY | 0.0% |
| 2023 Q3 | 23.62 Billion CNY | 1.96% |
| 2023 Q2 | 23.16 Billion CNY | 0.0% |
| 2022 Q4 | 21.98 Billion CNY | -0.09% |
| 2022 FY | 21.98 Billion CNY | 14.45% |
| 2022 Q1 | 20.52 Billion CNY | 6.81% |
| 2022 Q2 | 20.52 Billion CNY | 0.0% |
| 2022 Q3 | 22 Billion CNY | 7.25% |
| 2021 FY | 19.21 Billion CNY | 8.68% |
| 2021 Q2 | 18.54 Billion CNY | 0.0% |
| 2021 Q1 | 18.54 Billion CNY | 4.88% |
| 2021 Q3 | 19.21 Billion CNY | 3.62% |
| 2021 Q4 | 19.21 Billion CNY | 0.0% |
| 2020 Q1 | 17.6 Billion CNY | 18.87% |
| 2020 Q2 | 17.6 Billion CNY | 0.0% |
| 2020 Q3 | 17.67 Billion CNY | 0.42% |
| 2020 Q4 | 17.67 Billion CNY | 0.0% |
| 2020 FY | 17.67 Billion CNY | 19.37% |
| 2019 FY | 14.8 Billion CNY | 7.01% |
| 2019 Q1 | 14.89 Billion CNY | 7.65% |
| 2019 Q4 | 14.8 Billion CNY | 0.0% |
| 2019 Q3 | 14.8 Billion CNY | -0.6% |
| 2019 Q2 | 14.89 Billion CNY | 0.0% |
| 2018 Q1 | 13.63 Billion CNY | -0.84% |
| 2018 Q4 | 13.83 Billion CNY | 0.0% |
| 2018 Q3 | 13.83 Billion CNY | 1.48% |
| 2018 Q2 | 13.63 Billion CNY | 0.0% |
| 2018 FY | 13.83 Billion CNY | 0.63% |
| 2017 Q2 | 10.76 Billion CNY | 0.0% |
| 2017 Q3 | 13.75 Billion CNY | 27.76% |
| 2017 Q4 | 13.75 Billion CNY | 0.0% |
| 2017 FY | 13.75 Billion CNY | 24.59% |
| 2017 Q1 | 10.76 Billion CNY | -2.48% |
| 2016 Q1 | 10.88 Billion CNY | 64.16% |
| 2016 FY | 11.03 Billion CNY | 66.49% |
| 2016 Q4 | 11.03 Billion CNY | 0.0% |
| 2016 Q3 | 11.03 Billion CNY | 1.42% |
| 2016 Q2 | 10.88 Billion CNY | 0.0% |
| 2015 Q3 | 6.63 Billion CNY | 4.55% |
| 2015 Q2 | 6.34 Billion CNY | 0.0% |
| 2015 Q1 | 6.34 Billion CNY | 174.96% |
| 2015 FY | 6.63 Billion CNY | 187.47% |
| 2015 Q4 | 6.63 Billion CNY | 0.0% |
| 2014 FY | 2.3 Billion CNY | 81.85% |
| 2014 Q4 | 2.3 Billion CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2013 FY | 1.26 Billion CNY | -14.09% |
| 2013 Q4 | 1.26 Billion CNY | 0.0% |
| 2012 Q4 | 1.47 Billion CNY | 2.73% |
| 2012 FY | 1.47 Billion CNY | 0.0% |
| 2012 Q3 | 1.43 Billion CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 409.99 Million HKD | -5662.314% |
| CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | -110.049% |